100 related articles for article (PubMed ID: 7637409)
1. [Hyperdynamic circulatory syndrome of chronic liver disease: physiopathology of a multiorganic entity].
López-Talavera JC; Groszmann RJ
Med Clin (Barc); 1995 Jun; 105(1):13-5. PubMed ID: 7637409
[No Abstract] [Full Text] [Related]
2. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.
Iwakiri Y; Groszmann RJ
Hepatology; 2006 Feb; 43(2 Suppl 1):S121-31. PubMed ID: 16447289
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
5. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
6. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
Pérez-Páramo M; Muñoz J; Albillos A; Rossi I; Alvarez-Mon M; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(4):294-301. PubMed ID: 9721346
[TBL] [Abstract][Full Text] [Related]
8. [The effect of PGI2 on formation and development of hyperdynamic circulatory state in portal hypertensive rats].
Wu ZY; Chen XS; Cao H
Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):537-40. PubMed ID: 12921664
[TBL] [Abstract][Full Text] [Related]
9. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension.
Sogni P; Moreau R; Gadano A; Lebrec D
J Hepatol; 1995 Aug; 23(2):218-24. PubMed ID: 7499796
[No Abstract] [Full Text] [Related]
10. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
11. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
12. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathology of the hepato-renal syndrome. Renal function before and after pharmacological denervation of the kidney in the course of acute portal hypertension].
Bazzato G; Gordon SJ; Landini S; Lucatello S; Moracchiello M; Coli U; Fracasso A; Saggioro A; Galletti G; Onesti G
Minerva Nefrol; 1979; 26(1):25-32. PubMed ID: 471319
[No Abstract] [Full Text] [Related]
14. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.
Møller S
Dan Med Bull; 1998 Feb; 45(1):1-14. PubMed ID: 9504263
[No Abstract] [Full Text] [Related]
15. Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke.
Shah V
Hepatology; 2001 Nov; 34(5):1060-1. PubMed ID: 11679979
[No Abstract] [Full Text] [Related]
16. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats.
Ohta M; Tarnawski AS; Itani R; Pai R; Tomikawa M; Sugimachi K; Sarfeh IJ
Hepatology; 1998 Apr; 27(4):906-13. PubMed ID: 9537427
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
20. [Lung involvement in liver diseases].
Böker KH; Welte T
Dtsch Med Wochenschr; 1995 Jul; 120(30):1053-6. PubMed ID: 7628319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
